<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref34">
 <mixed-citation publication-type="journal" id="cit34">
  <name>
   <surname>Li</surname>
   <given-names>Y.</given-names>
  </name>; 
  <name>
   <surname>Lin</surname>
   <given-names>Z.</given-names>
  </name>; 
  <name>
   <surname>Zhao</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Xu</surname>
   <given-names>T.</given-names>
  </name>; 
  <name>
   <surname>Wang</surname>
   <given-names>C.</given-names>
  </name>; 
  <name>
   <surname>Hua</surname>
   <given-names>L.</given-names>
  </name>; 
  <name>
   <surname>Wang</surname>
   <given-names>H.</given-names>
  </name>; 
  <name>
   <surname>Xia</surname>
   <given-names>H.</given-names>
  </name>; 
  <name>
   <surname>Zhu</surname>
   <given-names>B.</given-names>
  </name>
  <article-title>Silver Nanoparticle Based Codelivery of Oseltamivir to Inhibit the Activity of the H1N1 Influenza Virus through ROS-Mediated Signaling Pathways</article-title>. 
  <source>ACS Appl. Mater. Interfaces</source>
  <year>2016</year>, 
  <volume>8</volume>, 
  <fpage>24385</fpage>â€“
  <lpage>24393</lpage>. 
  <pub-id pub-id-type="doi">10.1021/acsami.6b06613</pub-id>.
  <pub-id pub-id-type="pmid">27588566</pub-id>
 </mixed-citation>
</ref>
